Ovid Therapeutics

Ovid Therapeutics Overview

Founded 2014
Founded
Status Public
Employees 65
Employees
Stock Symbol OVID
Stock Symbol
Share Price $5.73 (As of Wednesday Closing)

Ovid Therapeutics General Information

Description

Ovid Therapeutics Inc is a US based biopharmaceutical company. The firm is engaged primarily in developing impactful medicines for patients and families living who are suffering with rare neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patient's life.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 1460 Broadway
  • Suite 15021
  • New York, NY 10036
  • United States
+1 (646) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ovid Therapeutics Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.73 $6.69 $1.53 - $7.21 $366M 54.8M 778K -$1.49

Ovid Therapeutics Financials Summary

In Thousands,
USD
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 86,298 160,530 7,155 146,792
Revenue 0 0 0 0
EBITDA (67,405) (61,155) (52,790) (64,927)
Net Income (66,691) (60,461) (51,980) (64,806)
Total Assets 61,723 80,844 47,650 89,458
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ovid Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ovid Therapeutics‘s full profile, request access.

Request a free trial

Ovid Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Ovid Therapeutics‘s full profile, request access.

Request a free trial

Ovid Therapeutics Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Auspex Pharmaceuticals Formerly VC-backed San Diego, CA 00 00000 000000&0 00000
0000000000 Formerly PE-Backed Germantown, MD 0 000.00 00000000 000.00
00000000 000000000 Formerly VC-backed Coral Gables, FL 00 000.00 00000000 000.00
000000000 Venture Capital-Backed New York, NY 000.00 00000000000 000.00
0000000 Venture Capital-Backed San Mateo, CA 00 000.00 00000 00000 000.00

Ovid Therapeutics Executive Team (14)

Name Title Board Seat Contact Info
Jeremy Levin Ph.D Chief Executive Officer & Chairman
Amit Rakhit MD Chief Medical Officer & President
Timothy Daly Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Dirk Haasner Ph.D Senior Vice President
Suzanne Wakamoto Senior Vice President, Human Resources

6 Former Executives

Ovid Therapeutics Board Members (6)

To view Ovid Therapeutics‘s full board member team, request access >>
Name Representing Role Since
Bart Friedman JD Self Board Member 000 0000
Douglas Williams Ph.D Self Board Member 000 0000
Howard Federoff Ph.D Self Chairman, Scientific Advisory Board 000 0000
Jeremy Levin Ph.D Ovid Therapeutics Chief Executive Officer & Chairman 000 0000
Karen Bernstein Ph.D Self Board Member 000 0000

1 Former Board Member